Boston Scientific (BSX) Long-Term Deferred Tax (2009 - 2026)

Boston Scientific (BSX) has 18 years of Long-Term Deferred Tax data on file, last reported at $4.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax rose 7.54% year-over-year to $4.0 billion; the trailing twelve-month figure through Mar 2026 stood at $4.0 billion (up 7.54% YoY), and the FY2025 full-year result was $3.7 billion, up 0.55% from the prior year.
• Long-Term Deferred Tax climbed to $4.0 billion in Q1 2026, from $3.7 billion in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $4.1 billion in Q1 2022 to a low of $3.7 billion in Q4 2024.
• A 5-year average of $3.8 billion and a median of $3.8 billion in 2023 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax slipped 4.92% in 2023 and advanced 7.54% in 2026, its largest moves.
• Tracing BSX's Long-Term Deferred Tax over 5 years: stood at $3.9 billion in 2022, then fell by 2.56% to $3.8 billion in 2023, then fell by 4.84% to $3.7 billion in 2024, then increased by 0.55% to $3.7 billion in 2025, then climbed by 7.56% to $4.0 billion in 2026.
• Business Quant data shows BSX's Long-Term Deferred Tax at $4.0 billion in Q1 2026, $3.7 billion in Q4 2025, and $3.7 billion in Q3 2025.